Scientific Abstracts

The following are scientific abstracts from various sources:

Adler, Gail K

• Reduced
hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia

Alarcon, Graciela

• Does
Chiari malformation contribute to fibromyalgia syndrome?

Arnold, Leslie M.

• Duloxetine with placebo in the treatment of FM patients
• Gabapentin in the treatment of fibromyalgia

Bennett, Robert

• Impaired
growth hormone secretion in FM patients
• Impact
of FM pain on health-related quality of life before & after tx with tramadol/acetaminophen

Bradley, Laurence A.

• Abnormalities
of regional cerebral blood flow
• Abnormal
functional activity of the central nervous system in FM

Bushnell, M. Catherine

• Accelerated
brain gray matter loss in fibromyalgia. Premature Aging of the brain?

Buskila D.

• Increased
Rates of Fibromyalgia Following Cervical Spine Injury A Controlled study of 161 Cases of Traumatic Injury
• Joint
hypermobility and fibromyalgia in school children
• Prevalance
of fibromyalgia syndrome in migraine patients

Caro, Xavier J.

• A
subset of FM patients have findings suggestive of CIDP
• A
subset of FM patients with findings suggestive of CIDP treated with IVIg

Clauw, Daniel J.

• Neurological
examination in individuals with fibromyalgia
• Prevalence
of Chiari malformation and cervical stenosis in fibromyalgia
• Efficacy
of milnacipran in patients with fibromyalgia
• Therapy
insight: fibromyalgia-a different type of pain needing a different type of treatment

Crofford, Leslie J.

• Neuroendocrine
abnormalities in fibromyalgia disorders
• Evidence
for and pathophysiologic implications of HPA axis dysregulation in FM and CFS
• Pregabalin
for the treatment of fibromyalgia syndrome

Gracely, Richard H.

• Functional
magnetic resonance imaging evidence of augmented pain
• Cerebrospinal
fluid corticotrophin-releasing factor

Harris, Richard E.

• Decreased
central µ-opioid receptor availability in fibromyalgia

Heffez, Dan S.

• Clinical
evidence for cervical myelopathy
• Is cervical
myelopathy overlooked in patients with fibromyalgia
• Is
there an association between cervical myelopathy and FM
• Can
spinal cord compression cause the fibromyalgia syndrome?
• Treatment
of cervical myelopathy in patients with the fibromyalgia syndrome

Holman, Andrew J.

• A
randomized double-blind placebo controlled trial of pramipexole

Jones, Kim D.

• Impaired
growth hormone secretion in FM patients
• Growth
hormone perturbation in fibromyalgia

Kranzler, Jay D.

• Development
of milnaciprin, a dual reuptake inhibitor for treatment of chronic pain

Krassioukov, Andrei

• Autonomic
dysfunction and pain in FM

Larson, Alice A.

• Changes
in the concentrations of amino acids in CSF that correlate with pain in FM

Marchand, Serge

• Spatial
summation for pain perception: interaction of inhibitory and excitatory mechanisms
• Widespread
pain in fibromyalgia is related to a deficit of endogenous pain inhibition
• Endogenous
pain inhibitory systems activated by spatial summation are opioid-mediated

Martinez-Lavin, Manuel

• Fibromyalgia
as a sympathetically maintained pain syndrome
• Is
fibromyalgia a generalized reflex sympathetic dystrophy?
• Norepinephrine-evoked
pain in fibromyalgia. A randomized pilot study

Mease, Philip J

• A
randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia

Milhorat, Thomas H.

• Chiari
I malformation redefined

Nicolelis, Miguel A.

• Dopaminergic
control of sleep-wake states

Pellegrino, Mark J.

• Prevalence
of mitral lapse prolapse in primary fibromyalgia: a pilot investigation

Pimentel, M.

• Eradication
of small intestinal bacterial overgrowth decreases symptoms in fibromyalgia: a double blind randomized study

Rosner, Michael J.

• The
neurosurgical subset of fibromyalgia Part I
• The
neurosurgical subset of fibromyalgia Part II
• The
neurosurgical subset of fibromyalgia Part III
• Fibromyalgia
Part IV: Long term outcome
• Neurally
mediated hypotension (NMH) and POTS Part I
• Neurally
mediated hypotension (NMH) and POTS Part II
• Neurally
mediated hypotension (NMH) and POTS Part III
• Treatment
of NMH with surgical decompression: 12 month follow-up

Rowe, Peter C.

• The
relationship between neurally mediated hypotension and CFS

Russell, I Jon

• Increased
concentrations of nerve growth factor in cerebrospinal fluid of patients with FM
• Advances
in fibromyalgia: Possible role for central neurochemicals
• Neurotransmitter
imbalances: Elevated CSF fluid levels of substance P in patients with FM
• Sodium
oxybate relieves pain and improves sleep...
• Pregabalin for management of fibromyalgia syndrome...

Scharf, Martin B.

• The
effects of sodium oxybate on clinical symptoms and sleep patterns in fibromyalgia

Staud, Roland

• Evidence
for abnormal pain processing in FM
• Neurobiology
of fibromyalgia syndrome
• Fibromyalgia
pain: Do we know the source?
• Body
pain area and pain-related negative affect
• Spatial
summation of heat pain within and across dermatomes
• Maintenance
of windup of second pain requires less frequent stimulation
• Evidence
of involvement of central neural mechanisms in generating FM

Thimineur, Mark

• Functional
abnormalities of the cervical cord and lower medulla

Watkins, Linda R.

• When
pain goes bad: Mighty glia be the culprit causing fibromyalgia?
• Spinal
gap junctions: Potential involvement in pain facilitation
• Activation
of the spinal cord complement cascade might contribute to mechanical allodynia
• Controlling
pathological pain by adenovirally driven spinal production
• Immune
regulation of central nervous system functions
• Immune-to-brain
communication dyanamically modulates pain
• The
glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain

Wilson, Russell B.

• Antipolymer
antibody reactivity in a subset of patients with FM correlates with severity

Wood, Patrick B.

• Stress
and dopamine: Implications for the pathophysiology of chronic widespread pain
• A
reconsideration of the relevance of systemic low-dose ketamine to the pathophysiology of fibromyalgia
• Open
trial of pindolol in the treatment of fibromyalgia
• Reduced
presynaptic dopamine activity in fibromyalgia syndrome
• Mesolimbic
dopaminergic mechanisms and pain control
• Accelerated
brain gray matter loss in fibromyalgia. Premature aging of the brain?

Yunus, Muhammad B.

• Genetic
linkage analysis of multicase families with fibromyalgia syndrome